Global Glutamate Receptor Ionotropic NMDA 2B Market
Strategic Market Analysis & Forecast (2026–2036)
Market Overview
The Glutamate Receptor Ionotropic NMDA 2B (NR2B) market represents a highly specialized segment of the central nervous system (CNS) therapeutics and neuropharmacology industry. NMDA 2B receptor modulators are being actively researched for their role in excitotoxicity regulation, synaptic plasticity, and neuroprotection, making them promising targets for both acute neurological injuries and chronic neurodevelopmental disorders.
The global NMDA 2B market was valued at USD XX million in 2020 and is projected to reach USD XX million by 2036, expanding at a CAGR of XX% during 2026–2036. Growth is primarily driven by rising neurological disease burden, unmet clinical needs in stroke and autism, and increasing pharmaceutical investment in receptor-selective CNS drugs.
Segments Analysis
By Product / Molecule Type
-
JNJ-0808
Selective NR2B antagonist under advanced CNS research -
Neu-2000
Neuroprotective candidate targeting ischemic injury -
NP-10679
Small-molecule NMDA receptor modulator -
NP-11948
Experimental NR2B-focused compound -
Radiprodil
One of the most clinically studied NR2B antagonists -
Next-Generation NR2B Modulators (Added)
Highly selective, reduced side-effect profiles -
Others
By Drug Development Stage (New Segmentation)
-
Preclinical
-
Phase I
-
Phase II
-
Phase III
-
Discontinued / Dormant Programs
By Application / Indication
-
Acute Ischemic Stroke
Largest research focus due to excitotoxic damage control -
Autism Spectrum Disorders
Targeting synaptic signaling abnormalities -
Brain Ischemia & Hypoxia
-
Burns & Trauma-Related Neurological Injury
-
Neurodegenerative Disorders (Added)
Alzheimer’s, Parkinson’s disease (research stage) -
Psychiatric Disorders (Added)
Depression, treatment-resistant mood disorders
By End User (New Segmentation)
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Academic & Research Institutes
-
Hospitals & Clinical Trial Centers
Key Market Players
Major Companies
-
BioCrea GmbH
-
Bristol-Myers Squibb
-
Cerecor
-
Johnson & Johnson
-
Luc Therapeutics
-
NeurOp
-
Novartis
-
UCB
Additional & Emerging Players (Added)
-
Pfizer
-
Roche
-
Takeda Pharmaceutical
-
Otsuka Pharmaceutical
-
Eli Lilly
Regional Analysis
North America
-
Largest share of R&D activity and clinical trials
-
Strong academic–industry collaboration
-
High CNS drug investment concentration
Europe
-
Robust neuroscience research ecosystem
-
Strong regulatory frameworks for rare and CNS disorders
-
Active participation in multicenter clinical trials
Asia-Pacific
-
Fastest-growing region for neuroscience research
-
Rising investment in CNS drug discovery in China and Japan
-
Expanding clinical trial infrastructure in India and South Korea
Central & South America
-
Limited clinical development activity
-
Growing participation in global trials
Middle East & Africa
-
Early-stage market
-
Primarily dependent on imported CNS therapeutics
Porter’s Five Forces Analysis
| Force | Impact |
|---|---|
| Threat of New Entrants | Low – high scientific and regulatory barriers |
| Supplier Power | Medium – specialized chemistry and R&D inputs |
| Buyer Power | Low – niche, innovation-driven market |
| Threat of Substitutes | Medium – alternative CNS pathways |
| Competitive Rivalry | Medium – pipeline-focused competition |
SWOT Analysis
Strengths
-
High scientific rationale and unmet medical need
-
Strong interest from global pharmaceutical companies
-
Potential for disease-modifying therapies
Weaknesses
-
High clinical failure rates in CNS drug development
-
Long development timelines and high R&D costs
Opportunities
-
Breakthrough therapies for stroke and autism
-
Precision medicine and receptor-selective drugs
-
Orphan drug and fast-track designations
Threats
-
Regulatory uncertainty in CNS indications
-
Competition from non-NMDA neurological targets
-
Safety concerns related to excitatory neurotransmission
Trend Analysis
-
Increasing focus on NR2B-selective antagonists
-
Shift from broad NMDA blockers to precision modulation
-
Growing interest in neuroprotection and synaptic repair
-
Expansion of collaborative research partnerships
-
Use of biomarkers and imaging endpoints in trials
Key Market Drivers
-
Rising prevalence of stroke and neurodevelopmental disorders
-
Lack of effective neuroprotective therapies
-
Advances in receptor-specific drug design
-
Increased CNS research funding
Challenges & Restraints
-
High attrition rate in CNS clinical trials
-
Blood–brain barrier penetration challenges
-
Safety and tolerability concerns
Value Chain Analysis
-
Target Identification & Validation
-
Medicinal Chemistry & Lead Optimization
-
Preclinical Studies
-
Clinical Trials (Phase I–III)
-
Regulatory Review
-
Commercialization & Licensing
Quick Strategic Recommendations for Stakeholders
-
Pharma Companies: Focus on highly selective NR2B modulators with improved safety profiles
-
Biotechs: Leverage partnerships with large pharma for late-stage development
-
Investors: Target early-stage platforms with strong IP and CNS expertise
-
Research Institutes: Expand translational neuroscience collaborations
-
Policy Makers: Support fast-track pathways for unmet neurological needs
Conclusion
The global Glutamate Receptor Ionotropic NMDA 2B market is a high-risk, high-reward pharmaceutical segment, driven by unmet neurological needs and advancing receptor biology. While clinical and regulatory challenges remain significant, successful NR2B-targeted therapies could represent transformational breakthroughs in neuroprotection and neurodevelopmental disorder treatment.
Table of Contents
Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2026
1 Industry Overview of Glutamate Receptor Ionotropic NMDA 2B
1.1 Definition and Specifications of Glutamate Receptor Ionotropic NMDA 2B
1.1.1 Definition of Glutamate Receptor Ionotropic NMDA 2B
1.1.2 Specifications of Glutamate Receptor Ionotropic NMDA 2B
1.2 Classification of Glutamate Receptor Ionotropic NMDA 2B
1.2.1 JNJ-0808
1.2.2 Neu-2000
1.2.3 NP-10679
1.2.4 NP-11948
1.2.5 Radiprodil
1.2.6 Others
1.3 Applications of Glutamate Receptor Ionotropic NMDA 2B
1.3.1 Acute Ischemic Stroke
1.3.2 Autism
1.3.3 Brasin Ischemia
1.3.4 Burns
1.3.5 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B
2.3 Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
2.4 Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B
3 Technical Data and Manufacturing Plants Analysis of Glutamate Receptor Ionotropic NMDA 2B
3.1 Capacity and Commercial Production Date of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
3.3 R&D Status and Technology Source of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
4 Global Glutamate Receptor Ionotropic NMDA 2B Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Glutamate Receptor Ionotropic NMDA 2B Capacity and Growth Rate Analysis
4.2.2 Glutamate Receptor Ionotropic NMDA 2B Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate Analysis
4.3.2 Glutamate Receptor Ionotropic NMDA 2B Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Glutamate Receptor Ionotropic NMDA 2B Sales Price
4.4.2 Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis (Company Segment)
5 Glutamate Receptor Ionotropic NMDA 2B Regional Market Analysis
5.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.1.2 North America E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.1.4 North America Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
5.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.2.2 Europe E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.2.4 Europe Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
5.3 China Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.3.1 China Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.3.2 China E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.3.4 China Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
5.4 Japan Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.4.1 Japan Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.4.2 Japan E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.4.4 Japan Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
5.5 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.5.1 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.5.2 Southeast Asia E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.5.4 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
5.6 India Glutamate Receptor Ionotropic NMDA 2B Market Analysis
5.6.1 India Glutamate Receptor Ionotropic NMDA 2B Market Overview
5.6.2 India E Glutamate Receptor Ionotropic NMDA 2B Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Glutamate Receptor Ionotropic NMDA 2B Sales Price Analysis
5.6.4 India Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
6 Global E Glutamate Receptor Ionotropic NMDA 2B Segment Market Analysis (by Type)
6.1 Global E Glutamate Receptor Ionotropic NMDA 2B Sales by Type
6.2 Different Types of Glutamate Receptor Ionotropic NMDA 2B Product Interview Price Analysis
6.3 Different Types of Glutamate Receptor Ionotropic NMDA 2B Product Driving Factors Analysis
6.3.1 JNJ-0808 Growth Driving Factor Analysis
6.3.2 Neu-2000 Growth Driving Factor Analysis
6.3.3 NP-10679 Growth Driving Factor Analysis
6.3.4 NP-11948 Growth Driving Factor Analysis
6.3.5 Radiprodil Growth Driving Factor Analysis
6.3.6 Others Growth Driving Factor Analysis
7 Global E Glutamate Receptor Ionotropic NMDA 2B Segment Market Analysis (by Application)
7.1 Global E Glutamate Receptor Ionotropic NMDA 2B Consumption by Application
7.2 Different Application of Glutamate Receptor Ionotropic NMDA 2B Product Interview Price Analysis
7.3 Different Application of Glutamate Receptor Ionotropic NMDA 2B Product Driving Factors Analysis
7.3.1 Acute Ischemic Stroke of Glutamate Receptor Ionotropic NMDA 2B Growth Driving Factor Analysis
7.3.2 Autism of Glutamate Receptor Ionotropic NMDA 2B Growth Driving Factor Analysis
7.3.3 Brasin Ischemia of Glutamate Receptor Ionotropic NMDA 2B Growth Driving Factor Analysis
7.3.4 Burns of Glutamate Receptor Ionotropic NMDA 2B Growth Driving Factor Analysis
7.3.5 Others of Glutamate Receptor Ionotropic NMDA 2B Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Glutamate Receptor Ionotropic NMDA 2B
8.1 BioCrea GmbH
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.3 Cerecor Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.4 Johnson & Johnson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.5 Luc Therapeutics, Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.6 NeurOp, Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.7 Novartis AG
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
8.8 UCB S.A.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution Analysis
9 Development Trend of Analysis of Glutamate Receptor Ionotropic NMDA 2B Market
9.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Trend Analysis
9.1.1 Global 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Sales Price Forecast
9.2 Glutamate Receptor Ionotropic NMDA 2B Regional Market Trend
9.2.1 North America 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.2.2 Europe 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.2.3 China 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.2.4 Japan 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.2.6 India 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast
9.3 Glutamate Receptor Ionotropic NMDA 2B Market Trend (Product Type)
9.4 Glutamate Receptor Ionotropic NMDA 2B Market Trend (Application)
10 Glutamate Receptor Ionotropic NMDA 2B Marketing Type Analysis
10.1 Glutamate Receptor Ionotropic NMDA 2B Regional Marketing Type Analysis
10.2 Glutamate Receptor Ionotropic NMDA 2B International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Glutamate Receptor Ionotropic NMDA 2B by Region
10.4 Glutamate Receptor Ionotropic NMDA 2B Supply Chain Analysis
11 Consumers Analysis of Glutamate Receptor Ionotropic NMDA 2B
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Glutamate Receptor Ionotropic NMDA 2B Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Glutamate Receptor Ionotropic NMDA 2B
Table Product Specifications of Glutamate Receptor Ionotropic NMDA 2B
Table Classification of Glutamate Receptor Ionotropic NMDA 2B
Figure Global Production Market Share of Glutamate Receptor Ionotropic NMDA 2B by Type in
Figure JNJ-0808 Picture
Table Major Manufacturers of JNJ-0808
Figure Neu-2000 Picture
Table Major Manufacturers of Neu-2000
Figure NP-10679 Picture
Table Major Manufacturers of NP-10679
Figure NP-11948 Picture
Table Major Manufacturers of NP-11948
Figure Radiprodil Picture
Table Major Manufacturers of Radiprodil
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Glutamate Receptor Ionotropic NMDA 2B
Figure Global Consumption Volume Market Share of Glutamate Receptor Ionotropic NMDA 2B by Application in
Figure Acute Ischemic Stroke Examples
Table Major Consumers in Acute Ischemic Stroke
Figure Autism Examples
Table Major Consumers in Autism
Figure Brasin Ischemia Examples
Table Major Consumers in Brasin Ischemia
Figure Burns Examples
Table Major Consumers in Burns
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Glutamate Receptor Ionotropic NMDA 2B by Regions
Figure North America Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Figure Europe Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Figure China Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Figure Japan Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Figure Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Figure India Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) (2013-2025)
Table Glutamate Receptor Ionotropic NMDA 2B Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B in
Figure Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
Figure Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B
Table Capacity and Commercial Production Date of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
Table Manufacturing Plants Distribution of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
Table R&D Status and Technology Source of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
Table Raw Materials Sources Analysis of Global Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Glutamate Receptor Ionotropic NMDA 2B E
Figure Global E Glutamate Receptor Ionotropic NMDA 2B Market Size (Volume) and Growth Rate
Figure Global E Glutamate Receptor Ionotropic NMDA 2B Market Size (Value) and Growth Rate
Table E Global Glutamate Receptor Ionotropic NMDA 2B Capacity and Growth Rate
Table Global Glutamate Receptor Ionotropic NMDA 2B Capacity (K Pcs) List (Company Segment)
Table E Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) and Growth Rate
Table Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) List (Company Segment)
Table E Global Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Table Global Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure North America E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure Europe E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure China E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure China Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure Japan E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure Japan Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure Southeast Asia E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B E
Figure India E Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs)
Figure India Glutamate Receptor Ionotropic NMDA 2B Sales Market Share
Table Global E Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type
Table Different Types Glutamate Receptor Ionotropic NMDA 2B Product Interview Price
Table Global E Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Application
Table Different Application Glutamate Receptor Ionotropic NMDA 2B Product Interview Price
Table BioCrea GmbH Information List
Table Product Overview
Table BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product Overview
Table Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table Cerecor Inc. Information List
Table Product Overview
Table Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table Johnson & Johnson Information List
Table Product Overview
Table Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table Luc Therapeutics, Inc. Information List
Table Product Overview
Table Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table NeurOp, Inc Information List
Table Product Overview
Table NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table Novartis AG Information List
Table Product Overview
Table Novartis AG Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Novartis AG Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Table UCB S.A. Information List
Table Product Overview
Table UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Business Region Distribution
Figure Global 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Glutamate Receptor Ionotropic NMDA 2B Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Glutamate Receptor Ionotropic NMDA 2B by Application 2018-2025
Table Traders or Distributors with Contact Information of Glutamate Receptor Ionotropic NMDA 2B by Region
Segments Analysis
By Product / Molecule Type
-
JNJ-0808
Selective NR2B antagonist under advanced CNS research -
Neu-2000
Neuroprotective candidate targeting ischemic injury -
NP-10679
Small-molecule NMDA receptor modulator -
NP-11948
Experimental NR2B-focused compound -
Radiprodil
One of the most clinically studied NR2B antagonists -
Next-Generation NR2B Modulators (Added)
Highly selective, reduced side-effect profiles -
Others
By Drug Development Stage (New Segmentation)
-
Preclinical
-
Phase I
-
Phase II
-
Phase III
-
Discontinued / Dormant Programs
By Application / Indication
-
Acute Ischemic Stroke
Largest research focus due to excitotoxic damage control -
Autism Spectrum Disorders
Targeting synaptic signaling abnormalities -
Brain Ischemia & Hypoxia
-
Burns & Trauma-Related Neurological Injury
-
Neurodegenerative Disorders (Added)
Alzheimer’s, Parkinson’s disease (research stage) -
Psychiatric Disorders (Added)
Depression, treatment-resistant mood disorders
By End User (New Segmentation)
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Academic & Research Institutes
-
Hospitals & Clinical Trial Centers
Key Market Players
Major Companies
-
BioCrea GmbH
-
Bristol-Myers Squibb
-
Cerecor
-
Johnson & Johnson
-
Luc Therapeutics
-
NeurOp
-
Novartis
-
UCB
